|
End-of-day quote
Korea S.E.
2026-08-28
|
5-day change | 1st Jan Change | ||
| 7,410.00 KRW | -1.59% |
|
-1.85% | -54.54% |
| 05-18 | TegoScience Inc. agreed to acquire 95.77% stake in PNP Pharm Co., Ltd. for KRW 3.7 billion. | CI |
| 25-05-26 | TegoScience Inc. announced that it has received KRW 27 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 43.05M | - | - | - | - | - |
| 79.3B | |||||
| 59.21B | |||||
| 55.09B | - | ||||
| 49.86B | |||||
| 47.9B |
- Stock Market
- Stocks
- A191420 Stock
- Charts TegoScience Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
